Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer

Ähnliche Einträge

• Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer
  von: Gen Lin, et al.
  Veröffentlicht: (2024)
• Mechanism research of non‐coding RNA in immune checkpoint inhibitors therapy
  von: Jie Bian, et al.
  Veröffentlicht: (2024)
• Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
  von: Georges Gebrael, et al.
  Veröffentlicht: (2024)
• Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B
  von: Joohyun Hong, et al.
  Veröffentlicht: (2024)
• Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non‐small cell lung cancer
  von: Shinkichi Takamori, et al.
  Veröffentlicht: (2025)